# Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

> **NCT03521700** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 150 (actual)

## Conditions studied

- Renal Artery Obstruction
- Stents
- Lipids
- Glomerular Filtration Rate
- Blood Pressure

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT03521700
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-01
- **Primary completion:** 2014-12-30
- **Final completion:** 2015-12-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521700, "Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03521700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*